Chemed (CHE) 2026 Jefferies Healthcare Services and Technology Conference summary
Event summary combining transcript, slides, and related documents.
2026 Jefferies Healthcare Services and Technology Conference summary
16 Sep, 2026State of the business and recent performance
Second quarter results exceeded expectations, leading to increased guidance for the year.
Roto-Rooter has stabilized despite higher marketing costs due to changes in Google's lead generation policies.
VITAS is performing above expectations, rebounding from last year's Medicare cap exposure in Florida.
Hospice business is highly predictable, supporting steady outlook.
Margin expansion and operational initiatives
Margin gains at VITAS are driven by EHR rollout, labor management, and strategic planning.
Guidance was raised twice due to strong operational execution and Florida expansion.
Recent Florida CON awards have contributed significantly to margin expansion.
New starts in Florida have created substantial cap cushion, supporting profitability.
Market outlook and demand trends
Demographic trends, especially in Florida, support strong long-term hospice demand.
By 2030, one in four Floridians will be over 65, boosting hospice opportunities.
Longer hospice stays save money for Medicare, reinforcing the value proposition.
Latest events from Chemed
- Q2 2026 revenue and earnings surged, led by VITAS growth and major share repurchases.CHE
Q2 2026 - VITAS drives robust growth and margin expansion, positioning for industry-leading hospice consolidation.CHE
43rd Annual J.P. Morgan Healthcare Conference 2025 - Admissions growth and CAP mitigation are ahead of plan, with strong execution in new markets.CHE
RBC Capital Markets Global Healthcare Conference 2026 - Raised hospice growth outlook, selective expansion, and digital strategies support margin gains.CHE
Bank of America Global Healthcare Conference 2026 - VITAS outperformed, boosting guidance, while Roto-Rooter faced margin pressure and revenue decline.CHE
Q1 2026 - Proxy details director elections, auditor ratification, pay-for-performance, and strong governance.CHE
Proxy filing - 2025 revenue up 4.1%, but margins and EPS fell; 2026 outlook is for stronger growth.CHE
Q4 2025 - Hospice growth remains robust with stable margins, while Roto-Rooter shows signs of recovery.CHE
Bank of America Home Care Conference - VITAS drives strong growth while Roto-Rooter adapts to competition and digital marketing shifts.CHE
UBS Global Healthcare Conference 2024